What is the Dose-Response Relationship between Vitamin D and Cancer Risk?

Nutrition Reviews

Volumn 65, Issue SUPPL.2, 2007, Pages

  Garland, Cedric F ^a,c   Grant, William B ^b   Mohr, Sharif B ^a   Gorham, Edward D ^a   Garland, Frank C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Sunlight   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; VITAMIN D;

DOSE RESPONSE; HUMAN; NEOPLASM; REVIEW; RISK FACTOR;

ANTICARCINOGENIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEOPLASMS; RISK FACTORS; VITAMIN D;

EID: 35148872638     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2007.tb00349.x     Document Type: Article

References (29)

1. Garland CF, Garland FC, Gorham ED, et al. The role of vitamin D in cancer prevention. Am J Public Health 2006;96:S252-S261.
2. Garland C., Garland F. Do sunlight and vitamin D reduce the likelihood of colon cancer Int J Epidemiol 1980;9:S227-S231.
3. Gorham E., Garland C., Garland F. Acid haze air pollution and breast and colon cancer in 20 Canadian cities. Can J Publ Health 1989;80:S96-S100.
4. Garland F., Garland C., Gorham E., Young Jr J. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 1990;19:S614-S622.
5. Grant WB. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002;94:S1867-S1875.
6. Grant W., Garland C. The association of solar ultraviolet B (UVB) with reducing risk of cancer: multi-factorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 2006;26:S2687-S2699.
7. Gorham ED, Garland CF, Garland FC, et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 2007;32:S210-S216.
8. Garland CF, Gorham ED, Mohr SB, et al. Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol 2007;103:S708-S711.
9. Tworoger SS, Lee IM, Buring JE, Rosner B., Hollis BW, Hankinson SE. Plasma 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D and risk of incident ovarian cancer. Cancer Epidemiol Biomarkers Prev 2007;16:S783-S788.
10. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academies Press; 1997. Available at: http:www.nap.edubooks0309063507html. Accessed June 22, 2007.
11. Vieth R. Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 2004;89-90:S575-S579.
12. Hathcock JN, Shao A., Vieth R., Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 2007;85:S6-S18.
13. Trang HM, Cole DE, Rubin LA, Pierratos A., Siu S., Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 1998;68:S854-S858.
14. Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004;89:S5387-S5391.
15. Houghton LA, Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 2006;84:S694-S697.
16. Chen TC, Chimeh F., Lu Z., et al. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys 2007;460:S213-S217.
17. Hollick M. Vitamin D: a millennium perspective. J Cell Biochem 2003;88:S296-S307.
18. Matsuoka L., Wortsman J., Holick M. Chronic sunscreen use decreases the concentration of 25-hy-droxyvitamin D: a preliminary study. Arch Dermatol 1988;124:S1802-S1804.
19. Palmer HG, Gonzalez-Sancho JM, Espada J., et al. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 2001;154:S369-S387.
20. Fernandez-Garcia NI, Palmer HG, Garcia M., et al. 1 alpha, 25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells. Onco-gene 2005;24:S6533-S6544.
21. Kip SN, Strehler EE. Vitamin D3 upregulates plasma membrane Ca2+-ATPase expression and potentiates apico-basal Ca2+ flux in MDCK cells. Am J Physiol Renal Physiol 2004;286:SF363-SF369.
22. Garland C., Garland F., Gorham E. Colon cancer parallels rickets. In: Lipkin M., Newmark H., Kelloff G., editors. Calcium, Vitamin D, and Prevention of Colon Cancer. Boca Raton: CRC Press; 1991:S81-S111.
23. Le TL, Yap AS, Stow JL. Recycling of E-cadherin: a potential mechanism for regulating cadherin dynamics. J Cell Biol 1999;146:S219-S232.
24. Barthel TK, Mathern DR, Whitfield GK, et al. 1, 25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism. J Steroid Biochem Mol Biol 2007;103:S381-S388.
25. Maruyama R., Aoki F., Toyota M., et al. Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation. Cancer Res 2006;66:S4574-S4583.
26. Ben-Shoshan M., Amir S., Dang DT, Dang LH, Weis-man Y., Mabjeesh NJ. 1alpha, 25-dihydroxyvitamin D3 (calcitriol) inhibits hypoxia-inducible factor-1/ vascular endothelial growth factor pathway in human cancer cells. Mol Cancer Ther 2007;6:S1433-S1439.
27. Lipkin M., Newmark H. Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med 1985;313:S1381-S1384.
28. Armenian HK. Incubation periods of cancer: old and new. J Chronic Dis 1987;40(Suppl 2):S9S-S15S.
29. Haddad JG, Chyu KJ. Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin En-docrinol Metab 1971;33:S992-S995.